• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 14, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Mapping residual esophageal tumors — a glimpse into the future?

Bioengineer by Bioengineer
January 10, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers at Osaka University find that mapping esophageal tumors that remain after chemotherapy can predict long-term prognosis and direct personalized treatment plans

IMAGE

Credit: Osaka University

Osaka, Japan – It’s one of the first questions asked by many newly-diagnosed cancer patients–“What are my chances of beating this?” Often there is no clear answer, with survival rates differing widely depending on the cancer stage and available treatment options. However, post-operative testing that provides an accurate prediction of long-term treatment outcomes is the next best thing to a crystal ball, allowing clinicians to plan further treatment or follow-up strategies and more accurately inform patients about their prognoses.

But is this possible? Researchers in Japan think that it might be, at least for esophageal cancer patients. In a recent study published in Annals of Surgery, a team led by researchers at Osaka University retrospectively examined tissue specimens from 120 esophageal cancer patients following treatment, allowing them to both assess tumor characteristics and investigate how these related to long-term treatment outcomes.

Esophageal cancer is the sixth most common cause of cancer-related death worldwide and, despite various treatment options, has a poor long-term prognosis. Most locally-advanced esophageal cancers are treated with neoadjuvant chemotherapy (NAC), which aims to increase the likelihood of successful curative surgery by reducing tumor size and eradicating systemic micro-metastases. Tissue specimens are usually examined after surgery to assess how a tumor has responded to chemotherapy treatment. However, standard methods do not map the remaining tumor cells to the different layers of the esophageal wall, and therefore provide an incomplete picture of treatment outcome.

The team hypothesized that there might be specific patterns of residual tumors after NAC, and that they might have different clinical implications for patients

The researchers therefore mapped the exact locations of residual tumors in the esophageal wall of patients after NAC and assessed whether tumor location was associated with clinicopathological parameters including specific oncological outcomes.

After NAC, they identified four tumor remnant patterns that are clearly different from those reported previously; the most common residual tumor pattern was a ‘shallow type.’ However, in approximately 40% of cases, tumor cells unexpectedly disappeared in the superficial (mucosal) layer of the esophageal wall, indicating that it would be difficult to diagnose whether or not tumor cells completely disappeared after NAC based only on an endoscopic mucosal biopsy. When the team examined associations between these patterns and disease factors, including prognosis, they found that pattern types 3 and 4 had higher risks of pleural dissemination and distant metastases than types 1 or 2. These results shows that patients displaying patterns 3 or 4 should have more regular follow-up appointments than those with pattern types 1 or 2. Interestingly, survival was similar among the four groups.

According to lead authors Tadayoshi Hashimoto and Tomoki Makino, these findings have significant clinical implications. They explained that by determining the tumor remnant pattern from resected specimens and post-operative image examination, a personalized treatment plan for each patient can be developed. This customized approach is expected to significantly improve esophageal cancer treatment outcomes.

###

The article, “The pattern of residual tumor after neoadjuvant chemotherapy for locally advanced esophageal cancer and its clinical significance”, was published in Annals of Surgery at doi: https://doi.org/10.1097/SLA.0000000000003129.

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan’s leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan’s most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university’s ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: https://resou.osaka-u.ac.jp/en/top

Media Contact
Saori Obayashi
[email protected]
81-661-055-886

Related Journal Article

http://dx.doi.org/10.1097/SLA.0000000000003129

Tags: cancerDiagnosticsMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Study Finds Teens with Elevated PFAS Levels Experience Greater Weight Regain After Bariatric Surgery

August 14, 2025
Clone Copy Number Diversity Predicts Lung Cancer Survival

Clone Copy Number Diversity Predicts Lung Cancer Survival

August 14, 2025

Groundbreaking Discovery Ignites New Hope for Breathing Recovery Following Spinal Cord Injuries

August 14, 2025

Breakthroughs in N-Type Thermoelectric Elastomers

August 14, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    79 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    58 shares
    Share 23 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Study Finds Teens with Elevated PFAS Levels Experience Greater Weight Regain After Bariatric Surgery

Clarifying Challenges in Lithium-Sulfur Batteries with Reduced Electrolyte Use

Clone Copy Number Diversity Predicts Lung Cancer Survival

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.